Executive Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$7.56M Buy
29,005
+4,549
+19% +$1.35M 0.59% 58
2024
Q3
$7.88M Buy
+24,456
New +$8M 0.62% 52
2024
Q2
Sell
-25,605
Closed -$7.25M 127
2024
Q1
$7.25M Sell
25,605
-5,070
-17% -$1.48M 0.64% 54
2023
Q4
$8.84M Buy
30,675
+442
+1% +$120K 0.83% 40
2023
Q3
$8.13M Buy
30,233
+726
+2% +$181K 0.84% 38
2023
Q2
$6.55M Buy
29,507
+4,282
+17% +$994K 0.68% 52
2023
Q1
$6.1M Sell
25,225
-5,153
-17% -$1.26M 0.68% 47
2022
Q4
$7.98M Buy
30,378
+24,674
+433% +$6.61M 0.98% 29
2022
Q3
$5.7K Sell
5,704
-19,586
-77% -$4.75M 0.79% 40
2022
Q2
$6.15M Sell
25,290
-8,785
-26% -$2.15M 0.83% 38
2022
Q1
$8.24M Buy
34,075
+3,948
+13% +$907K 0.89% 29
2021
Q4
$6.78M Buy
30,127
+1,387
+5% +$293K 0.67% 50
2021
Q3
$6.11M Buy
28,740
+279
+1% +$64.2K 0.67% 52
2021
Q2
$6.94M Buy
28,461
+24,125
+556% +$5.93M 0.76% 35
2021
Q1
$1.08M Buy
4,336
+1,392
+47% +$332K 0.13% 110
2020
Q4
$677K Buy
2,944
+449
+18% +$104K 0.08% 114
2020
Q3
$634K Buy
2,495
+257
+11% +$63.7K 0.09% 105
2020
Q2
$527K Sell
2,238
-1,419
-39% -$324K 0.08% 98
2020
Q1
$741K Sell
3,657
-1,765
-33% -$386K 0.13% 84
2019
Q4
$1.31M Buy
+5,422
New +$1.2M 0.18% 81
2019
Q3
Sell
-6,815
Closed -$1.26M 161
2019
Q2
$1.26M Buy
6,815
+754
+12% +$135K 0.18% 91
2019
Q1
$1.15M Sell
6,061
-693
-10% -$132K 0.21% 85
2018
Q4
$1.31M Buy
+6,754
New +$1.32M 0.23% 62

Other funds holding AMGN

Executive Wealth Management's AMGN Position: Q4 2024 in Review

Executive Wealth Management increased its Amgen (AMGN) stake by 19% in Q4 2024, buying an estimated $1.35M and bringing the position to 29,005 shares worth $7.56M. The position accounts for 0.59% of the portfolio, ranked #58.

Executive Wealth Management first reported a position in AMGN in Q4 2018 and has held it in 23 quarters since. The position peaked at $8.84M in Q4 2023. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Executive Wealth Management held 29,005 shares of Amgen worth $7.56M as of Q4 2024.
  • Executive Wealth Management bought 4,549 Amgen shares in Q4 2024, an estimated $1.35M.
  • Amgen made up 0.59% of Executive Wealth Management's portfolio in Q4 2024, its #58 holding.
  • Executive Wealth Management first reported a position in Amgen in Q4 2018 and has held it in 23 quarters since.
  • Executive Wealth Management's Amgen position peaked at $8.84M in Q4 2023.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.